Skip to main content
SpringerLink
Log in

Systolic Blood Pressure and Mortality in Patients on Hemodialysis

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Hypertension is extremely common in patients with end-stage renal disease who are receiving hemodialysis, and cardiovascular disease remains the leading cause of death in these patients. However, optimal blood pressure management strategies in this high-risk population are still controversial. This review first discusses the complex association of systolic blood pressure with clinical outcomes in patients on hemodialysis, with a focus on several recent studies. Next, it updates the reader on issues related to optimal timing and methods of blood pressure measurement, appropriate blood pressure targets, and pharmacologic and nonpharmacologic hypertension treatment strategies for patients on hemodialysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Agarwal R, Nissenson AR, Batlle D, et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115:291–7.

    Article  PubMed  Google Scholar 

  2. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13

  3. Kanbay M, Afsar B, Gusbeth-Tatomir P, Covic A. Arterial stiffness in dialysis patients: where are we now? Int Urol Nephrol. 2010;42:741–52.

    Article  PubMed  Google Scholar 

  4. Guerin AP, Pannier B, Marchais SJ, London GM. Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders. Curr Opin Nephrol Hypertens. 2006;15:105–10.

    Article  PubMed  Google Scholar 

  5. Foley RN, Parfrey PS, Harnett JD, et al. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 1996;49:1379–85.

    Article  PubMed  CAS  Google Scholar 

  6. Port FK, Hulbert-Shearon TE, Wolfe RA, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis. 1999;33:507–17.

    Article  PubMed  CAS  Google Scholar 

  7. Zager PG, Nikolic J, Brown RH, et al. “U” curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int. 1998;54:561–9.

    Article  PubMed  CAS  Google Scholar 

  8. Tozawa M, Iseki K, Iseki C, Takishita S. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int. 2002;61:717–26.

    Article  PubMed  Google Scholar 

  9. Li Z, Lacson Jr E, Lowrie EG, et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis. 2006;48:606–15.

    Article  PubMed  Google Scholar 

  10. Stidley CA, Hunt WC, Tentori F, et al. Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol. 2006;17:513–20.

    Article  PubMed  Google Scholar 

  11. Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int. 2000;58:2147–54.

    Article  PubMed  CAS  Google Scholar 

  12. •• Myers OB, Adams C, Rohrscheib MR, et al. Age, race, diabetes, blood pressure, and mortality among hemodialysis patients. J Am Soc Nephrol. 2010;21:1970–8. In a well-conducted analysis of 16,283 incident hemodialysis patients, Myers et al. demonstrated that lower predialysis SBP was associated with higher risk of death, but more so for older patients and for patients with diabetes mellitus. Although the mortality rate was lower for blacks than for whites, race was not a significant effect modifier of the association of SBP and mortality.

    Article  PubMed  Google Scholar 

  13. Chang TI, Friedman GD, Cheung AK, et al. Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study. J Hum Hypertens. 2011;25:98–105.

    Article  PubMed  CAS  Google Scholar 

  14. Agarwal R. Hypertension and survival in chronic hemodialysis patients–past lessons and future opportunities. Kidney Int. 2005;67:1–13.

    Article  PubMed  Google Scholar 

  15. Bos WJ, van Manen JG, Noordzij M, et al. Is the inverse relation between blood pressure and mortality normalized in ‘low-risk’ dialysis patients? J Hypertens. 2010;28:439–45.

    Article  PubMed  CAS  Google Scholar 

  16. Molnar MZ, Lukowsky LR, Streja E, et al. Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease. J Hypertens. 2010;28:2475–84.

    PubMed  CAS  Google Scholar 

  17. Agarwal R, Lewis RR. Prediction of hypertension in chronic hemodialysis patients. Kidney Int. 2001;60:1982–9.

    Article  PubMed  CAS  Google Scholar 

  18. Agarwal R, Peixoto AJ, Santos SF, Zoccali C. Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol. 2006;1:389–98.

    Article  PubMed  Google Scholar 

  19. Fagugli RM, Ricciardi D, Rossi D, et al. Blood pressure assessment in haemodialysis patients: comparison between pre-dialysis blood pressure and ambulatory blood pressure measurement. Nephrology. 2009;14:283–90.

    Article  PubMed  Google Scholar 

  20. Rahman M, Griffin V, Kumar A, et al. A comparison of standardized versus “usual” blood pressure measurements in hemodialysis patients. Am J Kidney Dis. 2002;39:1226–30.

    Article  PubMed  Google Scholar 

  21. Agarwal R, Brim NJ, Mahenthiran J, et al. Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension. 2006;47:62–8.

    Article  PubMed  CAS  Google Scholar 

  22. Khangura J, Culleton B, Manns B, et al. Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis. BMC Nephrol. 2010;11:13.

    Article  PubMed  Google Scholar 

  23. Agarwal R, Metiku T, Tegegne GG, et al. Diagnosing hypertension by intradialytic blood pressure recordings. Clin J Am Soc Nephrol. 2008;3:1364–72.

    Article  PubMed  Google Scholar 

  24. Alborzi P, Patel N, Agarwal R. Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol. 2007;2:1228–34.

    Article  PubMed  Google Scholar 

  25. • Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension. 2010;55:762–8. In this cross-sectional study, Agarwal demonstrated that home SBP was superior to routine in-center SBP to predict mortality. Home SBP between 120 and 130 mm Hg was associated with lowest mortality risk.

    Article  PubMed  CAS  Google Scholar 

  26. Agarwal R. Managing hypertension using home blood pressure monitoring among haemodialysis patients—a call to action. Nephrol Dial Transplant. 2010;25:1766–71.

    Article  PubMed  Google Scholar 

  27. Levin NW, Kotanko P, Eckardt KU, et al. Blood pressure in chronic kidney disease stage 5D-report from a kidney disease: improving global outcomes controversies conference. Kidney Int. 2010;77:273–84.

    Article  PubMed  Google Scholar 

  28. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1–S153.

    Google Scholar 

  29. Harper J, Nicholas J, Webb L, et al. UK renal registry 12th annual report (December 2009): chapter 11: blood pressure profile of prevalent patients receiving dialysis in the UK in 2008: national and centre-specific analyses. Nephron Clin Pract. 2010;115 Suppl 1:c239–60.

    Article  PubMed  Google Scholar 

  30. Davenport A, Cox C, Thuraisingham R. Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int. 2008;73:759–64.

    Article  PubMed  CAS  Google Scholar 

  31. Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009;4:914–20.

    Article  PubMed  Google Scholar 

  32. Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int. 2004;66:1212–20.

    Article  PubMed  Google Scholar 

  33. Tislér A, Akócsi K, Borbás B, et al. The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis. Nephrol Dial Transplant. 2003;18:2601–5.

    Article  PubMed  Google Scholar 

  34. Tislér A, Akócsi K, Hárshegyi I, et al. Comparison of dialysis and clinical characteristics of patients with frequent and occasional hemodialysis-associated hypotension. Kidney Blood Pres Res. 2002;25:97–102.

    Article  Google Scholar 

  35. Tai DJ, Lim TW, James MT, et al. Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis. Clin J Am Soc Nephrol. 2010;5:623–30.

    Article  PubMed  Google Scholar 

  36. • Agarwal R, Sinha AD. Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis. Hypertension. 2009;53:860–6. In this well-conducted meta-analysis of five randomized clinical trials of patients on hemodialysis, Agarwal and Sinha demonstrated that treatment with antihypertensive medications reduced cardiovascular events and death in hemodialysis patients

    Article  PubMed  CAS  Google Scholar 

  37. • Heerspink HJL, Ninomiya T, Zoungas S, et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2009;373:1009–15. In this meta-analysis of eight randomized clinical trials of patients on hemodialysis and peritoneal dialysis, antihypertensive medication treatment was associated with a lower risk of all-cause and cardiovascular mortality and morbidity.

    Article  PubMed  Google Scholar 

  38. Chazot C. Can chronic volume overload be recognized and prevented in hemodialysis patients? use of a restricted-salt diet. Semin Dial. 2009;22:482–6.

    Article  PubMed  Google Scholar 

  39. Maduell F, Navarro V. Dietary salt intake and blood pressure control in haemodialysis patients. Nephrol Dial Transplant. 2063;2000:15.

    Google Scholar 

  40. Munoz Mendoza J, Sun S, Chertow GM, et al. Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach? Nephrol Dial Transplant. 2011;26:1281–7.

    Article  PubMed  CAS  Google Scholar 

  41. Manlucu J, Gallo K, Heidenheim PA, Lindsay RM. Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system. Am J Kidney Dis. 2010;56:69–76.

    Article  PubMed  CAS  Google Scholar 

  42. Agarwal R, Weir MR. Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5:1255–60.

    Article  PubMed  Google Scholar 

  43. Kayikcioglu M, Tumuklu M, Ozkahya M, et al. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant. 2009;24:956–62.

    Article  PubMed  Google Scholar 

  44. Agarwal R, Alborzi P, Satyan S, Light RP. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension. 2009;53:500–7.

    Article  PubMed  CAS  Google Scholar 

  45. Charra B, Chazot C, Jean G, et al. Long 3 × 8 hr dialysis: a three-decade summary. J Nephrol. 2003;16 Suppl 7:S64–9.

    PubMed  Google Scholar 

  46. •• FHN Trial Group, Chertow GM, Levin NW, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363:2287–300. In this well-conducted clinical trial, 245 patients were randomly assigned to receive in-center hemodialysis six times per week or three times per week. Patients who received more frequent hemodialysis had benefits in the co-primary outcomes (death or increase in left ventricular mass, and death or decrease in physical composite score), as well as in prespecified secondary outcomes related to hypertension: lower predialysis SBP and fewer antihypertensive medications used.

    Article  PubMed  CAS  Google Scholar 

  47. Inrig JK. Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis. Am J Kidney Dis. 2010;55:580–9.

    Article  PubMed  CAS  Google Scholar 

  48. Inrig JK, Oddone EZ, Hasselblad V, et al. Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int. 2007;71:454–61.

    Article  PubMed  CAS  Google Scholar 

  49. U S Renal Data System, USRDS 2010 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010

Download references

Acknowledgments

I thank Drs. Glenn M. Chertow and Jeffry Young for their critical review of this manuscript.

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. 780 Welch Road, Suite 106, Palo Alto, CA, 94304, USA

    Tara I. Chang

Authors
  1. Tara I. Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tara I. Chang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, T.I. Systolic Blood Pressure and Mortality in Patients on Hemodialysis. Curr Hypertens Rep 13, 362–369 (2011). https://doi.org/10.1007/s11906-011-0223-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-011-0223-x

Keywords

Search

Navigation